BeyondSpring (BYSI) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free BYSI Stock Alerts $2.43 +0.14 (+6.11%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBeyondSpring Inc. (NASDAQ:BYSI) Sees Significant Increase in Short Interestmarketbeat.com - March 30 at 2:37 PMBeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancerglobenewswire.com - March 25 at 7:00 AMBYSI Oct 2024 7.500 callfinance.yahoo.com - March 14 at 10:16 AM4,958,143 Shares in BeyondSpring Inc. (NASDAQ:BYSI) Bought by Decheng Capital Management III Cayman LLCmarketbeat.com - March 13 at 8:45 AMBYSI Mar 2024 7.500 callfinance.yahoo.com - March 7 at 9:38 AMU.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.04%msn.com - March 6 at 7:22 PMRetail investors invested in BeyondSpring Inc. (NASDAQ:BYSI) up 125% last week, insiders too were rewardedfinance.yahoo.com - March 6 at 7:22 PMBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirementsfinance.yahoo.com - March 5 at 10:11 AMBeyondSpring Inc. (BYSI) stock historical prices & data – Yahoo Financeuk.finance.yahoo.com - February 22 at 5:24 PMBeyondSpring Inc BYSImorningstar.com - January 18 at 10:07 AMBeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-Kfinance.yahoo.com - January 18 at 10:07 AMBeyondSpring gets Nasdaq delinquency noticemsn.com - January 11 at 10:09 AMBeyondSpring Stock (NASDAQ:BYSI) Insider Tradesbenzinga.com - December 27 at 6:59 PMBeyondSpring Stock (NASDAQ:BYSI) Dividends: History, Yield and Datesbenzinga.com - December 27 at 6:59 PMOncternal slips after early data for lymphoma therapyseekingalpha.com - December 26 at 1:28 PMPassage Bio stock climbs 9% on dementia study, program updatemsn.com - December 20 at 7:12 PMBeyondSpring regains compliance with Nasdaq minimum bid price rulemsn.com - October 31 at 2:14 PMBeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Modelsfinance.yahoo.com - October 31 at 9:13 AMBeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - October 30 at 1:35 PMSEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposiummarkets.businessinsider.com - October 26 at 1:36 PMSEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directorsstockhouse.com - October 23 at 9:18 AMBeyondSpring, Inc.: BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirementsfinanznachrichten.de - October 5 at 1:44 PMBeyondSpring and Leading Cancer Center to Present Poster at SITC's 38th Annual Meetingbenzinga.com - September 27 at 2:42 PMBeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meetingfinance.yahoo.com - September 27 at 2:42 PMBeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conferencefinance.yahoo.com - September 7 at 8:30 AMSEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directorsfinance.yahoo.com - June 20 at 10:22 AMBeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin’s Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCTfinance.yahoo.com - June 7 at 11:17 AMIs BeyondSpring (NASDAQ:BYSI) In A Good Position To Invest In Growth?finance.yahoo.com - May 22 at 12:25 PMBeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meetingfinance.yahoo.com - May 18 at 10:39 AMBeyondSpring Provides Business Update and Reports Year End 2022 Financial Resultsfinance.yahoo.com - April 18 at 8:34 PMBeyondSpring Files 2022 Annual Report on Form 20-Ffinance.yahoo.com - April 18 at 8:34 PMBeyondSpring Inc. (BYSI) stock price, news, quote & history – Yahoo Financesg.finance.yahoo.com - April 18 at 10:33 AMBeyondSpring Inc. (BYSI) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - March 19 at 12:37 PMBeyondSpring First Half 2022 Earnings: US$0.47 loss per share (vs US$0.93 loss in 1H 2021)finance.yahoo.com - March 2 at 7:40 AMBeyondSpring Enrolls First Patient in Phase 2 Study with Plinabulin, Keytruda and Docetaxel in Patients with Metastatic Non-Small Cell Lung Cancer Who Progressed After Immunotherapyfinance.yahoo.com - March 1 at 11:38 AMBeyondSpring Receives Notifications from Nasdaq Regarding Compliance With Listing Rulesfinance.yahoo.com - January 9 at 6:12 PMIndividual investors who hold 50% of BeyondSpring Inc. (NASDAQ:BYSI) gained 153%, insiders profited as wellfinance.yahoo.com - December 20 at 2:55 PMWhy Are BeyondSpring Shares Trading Higher?finance.yahoo.com - December 13 at 9:37 PMBeyondSpring Presents Positive Data with Plinabulin for the Prevention of Docetaxel-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer and Breast Cancer at Three Medical Conferencesfinance.yahoo.com - December 13 at 8:23 AMBeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirementsfinance.yahoo.com - November 23 at 6:45 PMEngland could be in drought beyond spring 2023, say ministers - The Guardiantheguardian.com - October 14 at 8:45 AMBeyondSpring Inc. (BYSI)uk.finance.yahoo.com - September 29 at 4:10 PMBeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022 - Yahoo Financefinance.yahoo.com - September 13 at 3:55 PMBeyondSpring's Lead Cancer Drug Protects Bone Marrow Stem Cells Within 24 Hoursfinance.yahoo.com - September 13 at 3:55 PMBeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022 - GlobeNewswireglobenewswire.com - September 13 at 9:25 AMBeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022finance.yahoo.com - September 13 at 9:25 AMBeyondSpring Q2 2022 Earnings Preview - Seeking Alphaseekingalpha.com - September 8 at 3:15 PMBeyondSpring Presents New Data From Lead Asset On Neutropenia In Multiple Myeloma Patients - Yahoo Financefinance.yahoo.com - August 29 at 11:51 PMBeyondSpring Presents New Data From Lead Asset On Neutropenia In Multiple Myeloma Patientsfinance.yahoo.com - August 29 at 6:50 PMBeyondSpring Presents New Data for the Use of Plinabulin and Pegfilgrastim to Decrease Neutropenia Burden in Peri-Transplant Multiple Myeloma Patients at the 19th International Myeloma Society Annual Meeting - GlobeNewswireglobenewswire.com - August 29 at 9:27 AM Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address The "Smart Money" Is Ready for May 1st Are You? (Ad)Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… BYSI Media Mentions By Week BYSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BYSI News Sentiment▼0.000.43▲Average Medical News Sentiment BYSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BYSI Articles This Week▼00▲BYSI Articles Average Week Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VTVT News Today ASMB News Today AVRO News Today BLRX News Today SABS News Today BCLI News Today LIAN News Today ACST News Today FRLN News Today LPCN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BYSI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
